Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

PGD2 stops hair growth and is higher in bald men with AGA.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Estrogen therapy can reduce skin aging but has cancer risks.

Finasteride safely lowers DHT levels without affecting testosterone.

Too much androgen can cause hair loss; finasteride may help.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Antioxidants can benefit skin health but should be used carefully to avoid negative effects.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.